Financials
- Financial year
- 2025
- Total assets
- €669,461
- Loss
- -€207,919
- Solvency
- 16.6%
Total assets▼ 29.2%
Net result
20182025
BIOCONTROL
ActiveSummary
The annual accounts of BIOCONTROL for financial year 2025 show a net loss of 65% of the equity at the start of that year. The 2025 annual accounts show equity of €111,164 and a net result of -€207,919. Equity remains stable across the filed financial years (±2.1% per year). Its solvency ranks better than 32% of 267 sector peers (NACE 72, financial year 2025). The company has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.9% (low).
Overview
Activity
Other research and development on natural sciences
NACE 72109
#2 oldest company in West Flanders, Research and development sector1 site
Size
€669,461total assets 2025
- Equity
- €111,164
- Loss
- -€207,919
Turnover not published (abbreviated or micro format)
Structure
- Parent
- Labotoxico · 100%
Accounts filed 31 days late0 of 2 deeds read
Why 53raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €207,919, the second in a row (financial year 2025)Latest accounts 31 days late; 1 of the last 3 lateLiquidity: current ratio 0.24, cash €3,944lowers riskSize: total assets €669,461Show the evidence
Checked score
Score 2025
53
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 16% of its sector peers (NACE 72, micro)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency
42-17
equity 16.6% of total assets
Liquidity
5-15
short-term debt 83.4% · cash 0.6%
Profitability
0-68
return on assets -31.1%
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%lowest value
12-2024: 0.1%● unchanged vs 11-2024lowest value
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025lowest value
08-2025: 0.1%● unchanged vs 07-2025lowest value
09-2025: 0.1%● unchanged vs 08-2025lowest value
10-2025: 0.1%● unchanged vs 09-2025lowest value
11-2025: 0.1%● unchanged vs 10-2025lowest value
12-2025: 0.1%● unchanged vs 11-2025lowest value
01-2026: 0.1%● unchanged vs 12-2025lowest value
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.4%▲ +0.3 percentage points vs 07-2026
09-2026: 0.9%▲ +0.5 percentage points vs 08-2026highest value
10-2026: 0.9%● unchanged vs 09-2026highest value
Credit of up to €5,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity insufficient (current ratio 0.24, compared with 0.7 in 2024; short-term debt: 83.4% and cash: 0.6% of total assets), and 83.4% of the assets are financed with debt.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 28% on solvency, 4% on liquidity, 21% on profitability and 13% on growth.
The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
−lowers risk+raises risk○neutral
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€207,919
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are in a legal situation other than normal, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
31 days late
2024
43 days early
2023
2 days early
2022
15 days early
2021
1 day early
2020
26 days late
2019
37 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 6 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Weakest financial yearnet -€207,919
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
By topic
Board & ownership
- Parent
- Labotoxico · 100%
Timeline
- Events
- 39
- Since
- 1990
- Next accounts
- by 31-07-2027
- 29-07-2024Annual accounts filed
- 16-07-2023Annual accounts filed
- 30-07-2022Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Other research and development on natural sciencesNACE 72109
- Founded
- 05-04-1988
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.